The results demonstrated that high expression of CK19 (KRT19), Ki67 (MKI67), and β-catenin (CTNNB1) was negatively correlated with overall survival (OS) in HCC patients, with higher expression levels corresponding to lower survival rates (Fig. 2). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.